Enanta Pharmaceuticals
ENTA
ENTA
124 hedge funds and large institutions have $549M invested in Enanta Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 36 increasing their positions, 42 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
14% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 42
62% less call options, than puts
Call options by funds: $1.13M | Put options by funds: $2.97M
Holders
124
Holding in Top 10
3
Calls
$1.13M
Puts
$2.97M
Top Buyers
| 1 | +$27.3M | |
| 2 | +$20.2M | |
| 3 | +$13.1M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$9.34M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.45M |
Top Sellers
| 1 | -$26.6M | |
| 2 | -$9.89M | |
| 3 | -$8.4M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$6.19M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$5.44M |